FDA Investigator: Carl Lee
- Carl Lee first started conducting FDA inspections in 2000, with the last inspection in 2014. Over that time, Carl Lee has conducted 140 inspections at 124 companies across 128 sites.
Get Carl Lee's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Zhejiang Jiuzhou Pharmaceutical Co Ltd Linhai Branch, Linhai, Taizhou | 2014
Out-of-stock
Carl Lee
Human Drug Form 483
FDA 483 China National Analytical Center, Guangzhou City | 2014
Out-of-stock
Carl Lee
Human Drug Form 483
FDA 483 China Resources Sanjiu Medical and Pharmaceutical Co., Ltd., Shenzhen | 2014
Out-of-stock
Carl Lee
Human Drug Form 483
FDA 483 Yibin Lihao Bio-technical Co., Ltd., Yibin | 2014
Out-of-stock
Carl Lee
Human Drug Form 483
FDA 483 Beijing Yandu Limin Slaughter House Co., Ltd., Liulihe Town, Fangshan District | 2014
Out-of-stock
Carl Lee
Human Drug Form 483
FDA 483 Gilead Sciences Inc, Foster City | 2013
Out-of-stock
Carl Lee
Human Drug Form 483
FDA 483 Northeast Pharmaceutical Group Co., Ltd., Shenyang | 2012
Out-of-stock
Carl Lee
Human Drug Form 483
FDA 483 Asahi Glass Co., Ltd., Ichihara | 2011
Out-of-stock
Carl Lee
Human Drug Form 483
FDA 483 R-Tech Ueno, Ltd., Chuo-ku, Kobe City | 2011
Out-of-stock
Carl Lee
Human Drug Form 483
FDA 483 Genentech, Inc., South San Francisco | 2011
Out-of-stock
Carl Lee
Human Drug Form 483
FDA 483 Dr. Wanchai Dejsomritrutai, Bangkok | 2009
Out-of-stock
Carl Lee
Human Drug Form 483
FDA 483 Ein-Sik Lee, Chongno- Ku | 2009
Out-of-stock
Carl Lee
Human Drug Form 483
FDA 483 Shanghai No. 1 Biochemical & Pharmaceutical Co., Ltd., Shanghai | 2008
Out-of-stock
Carl Lee
Human Drug Form 483
Co-Investigators (47)
- Jeffrey D. Meng, FDA Investigator
- Gang Wang, FDA Investigator
- Kim L. Thomas Cruse, FDA Investigator
- Thomas Cruse, Kim L, FDA Investigator
- Peter E. Baker, FDA Investigator
- Lance M. De Souza, FDA Investigator
- De Souza, Lance M, FDA Investigator
- Henry K. Lau, FDA Investigator
- Zi-Qiang Gu, FDA Investigator
- Susan W. Ting, FDA Investigator
- Brenda W. Uratani, FDA Investigator
- Albinus M. D Sa, FDA Investigator
- D Sa, Albinus M, FDA Investigator
- Sangeeta M. Khurana, FDA Investigator
- Sixto M. Mercado Rios, FDA Investigator
- Mercado Rios, Sixto M, FDA Investigator
- Stuart W. Russell, FDA Investigator
- Raymond T. Oji, FDA Investigator
- Joseph P. Iser, FDA Investigator
- Kevin P. Foley, FDA Investigator
- Mariza M. Jafary, FDA Investigator
- Roger D. Gawne, FDA Investigator
- Rebecca E. Sulpacio, FDA Investigator
- Maida Henesian, FDA Investigator
- John A. Liu, FDA Investigator
- Mark E. Baldwin, FDA Investigator
- Erica R. Pomeroy, FDA Investigator
- Melody M. Ragasa-Leong, FDA Investigator
- Elisabeth A. Drevet, FDA Investigator
- Melody M. Ragasa Leong, FDA Investigator
- Marie K. Kinkade, FDA Investigator
- Jeffrey M. Watson, FDA Investigator
- Robert W. Jennings, FDA Investigator
- Rochelle B. Young, FDA Investigator
- Gerald N. McGirl, FDA Investigator
- Randall P. Zielinski, FDA Investigator
- Vebina K. Sethi, FDA Investigator
- Mark I. Nakano, FDA Investigator
- Elsa Y. Yu, FDA Investigator
- William J. Weis, FDA Investigator
- Mary C. Acton, FDA Investigator
- Alice A. Blair, FDA Investigator
- Mark E. Chan, FDA Investigator
- Carol A. Llewellyn, FDA Investigator
- Joan T. Briones, FDA Investigator
- Daniel C. Geffin, FDA Investigator
- Juan A. Morales, FDA Investigator